BSPCE 2026: valuation, taxation, PEA and apport for startups

Updated 28 October 2025.

BSPCE (Bons de Souscription de Parts de Créateur d'Entreprise) remain in 2026 the most tax-efficient equity incentive available to eligible French private companies. Codified in article 163 bis G of the French Tax Code (CGI) since 1998, the regime has been refined several times, most recently with the opening to PEA by the 2024 Finance Act — a structural shift that changes founders' arbitrage.

For US, UK or other foreign founders setting up or investing in a French start-up, BSPCE often replace stock options as the equity incentive of choice. This article maps the 2026 framework from official French sources (Légifrance, BOFIP, entreprendre.service-public.fr).

A BSPCE is a warrant entitling the holder to subscribe to newly issued shares at a price fixed at the grant date. The beneficiary:

• receives the warrants (often subject to vesting);
• exercises by paying the strike price → becomes a shareholder;
• sells the shares and realises the gain.

The net gain on sale (sale price − strike price) is taxed under the specific article 163 bis G CGI regime.

Three stages, three tax moments#

The tax neutrality at stages 1 and 2 is what makes BSPCE strictly more attractive than US-style stock options or French AGA (free shares).

2.1 Issuing company#

The company must (article 163 bis G I CGI):

• be a joint-stock company (SA, SAS, SCA);
• have been registered for less than 15 years at the grant date;
• be subject to French corporate tax (IS), or an equivalent EU/EEA corporate tax;
• have at least 25 % of share capital held directly and continuously by individuals or by entities themselves held 75 % or more by individuals;
• not derive from a merger, restructuring, extension or take-over of pre-existing activities (with limited exceptions).

Listed companies may grant BSPCE if their market capitalisation is below €150m.

2.2 Eligible beneficiaries#

BSPCE may only be granted to:

• employees of the issuing company;
• directors taxed as employees for income tax purposes (e.g. SAS président, directeur général);
• board / supervisory board members;
• employees and directors of 75 %-owned subsidiaries (under conditions).

External consultants and advisors are excluded unless they become employees.

The strike price is set at grant and cannot be amended later. Article 163 bis G requires consistency with fair market value.

Statutory rule#

If the company carried out a capital increase in the six months preceding the grant, the strike price must be at least equal to the issue price of that round (with adjustments for differential rights). Otherwise, the strike price must reflect fair market value.

Methods used in practice#

• last round price (preferred when a recent funding round exists);
• comparable transactions (mid-market sectors with observable multiples);
• discounted cash-flow (stable business models);
• asset-based approach (very early-stage);
• independent valuation report (recommended for audit-ready files).

Field perspective. After a Series A, last-round pricing is usually the most defensible. For pre-revenue companies without a recent external round, an independent valuation memorandum or a signed letter from the company's accountant is market standard.

Re-characterisation risk#

A clearly understated strike price exposes the beneficiary to a re-characterisation as salary benefit in kind, taxed at the progressive income tax rate plus social charges — entirely defeating the BSPCE advantage.

4.1 Standard regime (article 163 bis G CGI)#

For BSPCE exercised since 2025, the 2025 Finance Act splits the gain in two:

• the exercise gain (value of the shares on the exercise date − strike price), taxed at 12.8% income tax if the beneficiary has worked in the company for at least three years, 30% otherwise, plus social levies;
• the capital gain on sale (sale price − value on the exercise date), taxed as an ordinary securities gain: 31.4% flat tax (12.8% + 18.6% social levies) or the progressive scale on a global option.

For warrants exercised before the reform, the net gain on sale (sale price − strike price) is still taxed as a whole according to tenure:

The exceptional contribution on high incomes (CEHR, article 223 sexies CGI) may add 3 % above €250,000 of reference fiscal income for a single filer (€500,000 for a couple), 4 % above €500,000 (€1,000,000 for a couple).

4.2 BSPCE in a PEA — the 2024 reform confirmed for 2026#

Since the 2024 Finance Act (Law 2023-1322, article 8), BSPCE shares can be held in a PEA or PEA-PME, provided:

• shares are credited to the plan at the time of subscription;
• the strike price is paid in cash from the PEA's cash account;
• the issuing company meets PEA eligibility criteria (EU/EEA seat, EU corporate tax, eligible activity).

Tax effect: after five years of plan holding, the net gain on sale becomes income tax exempt (18.6% social levies still apply). For large gains, the income tax saving can be material.

Field perspective. PEA eligibility is a real opportunity, but the PEA cap of €150,000 (€225,000 combined PEA + PEA-PME) is a hard constraint. The cash strike price must fit within the cap — which excludes BSPCE with a high strike after several rounds.

After exercise, the beneficiary may contribute the shares to a personal holding company they control, benefiting from tax deferral under article 150-0 B ter CGI.

Mechanics:

• the contribution itself is tax-neutral: no immediate taxation of the latent capital gain;
• the holding holds the shares and can collect dividends under the parent-subsidiary regime (article 145 CGI, exemption with a 5 % share-of-expenses add-back);
• if the holding sells the shares within three years of the contribution, the deferral falls unless the holding reinvests at least 70 % of the sale proceeds (for disposals carried out on or after 21 February 2026, Law no. 2026-103 of 19 February 2026) in an eligible economic activity within three years, with the reinvested assets held for five years, against 60 % within two years previously.

For a founder, the apport-cession sequence after a BSPCE exercise allows long-term income tax deferral and structured cash flow through the holding. The structure must be set up before an imminent sale, otherwise the French tax authority may invoke abuse of law (article L.64 LPF). See our apport-cession guide.

1. No rolling BSPCE plan. A seed-stage grant at €1 per share becomes unusable after a Series B at €80 per share — beneficiaries no longer exercise. A rolling plan, refreshed at each round, is critical.
2. Late exercise. Many beneficiaries wait until a sale to exercise, missing the 3-year tenure clock. For a founder planning an exit at 5-7 years, exercising as soon as cash permits triggers the favourable timer.
3. Skipping PEA eligibility. Subscription must be made directly within the PEA. Later transfer is not possible. The choice belongs at exercise design stage.
4. Exit-tax confusion with AGA. Unexercised BSPCE are out of the exit-tax base (article 167 bis CGI), unlike vested AGA. Pre-departure exercise timing matters. See our Exit Tax 2026 guide.

BSPCE vs stock options vs AGA?#

BSPCE: warrants, tax-neutral at grant and exercise, taxed only at sale under article 163 bis G CGI. Reserved for non-listed companies under 15 years old. Stock options: purchase rights on shares, less favourable tax, open to any company. AGA (free shares): granted at no cost, taxation split between acquisition gain (salary-like) and sale gain (capital gains).

Can BSPCE sit in a PEA in 2026?#

Yes, since the 2024 Finance Act (article 8). Cumulative conditions: shares booked into the plan at subscription, strike price paid from the PEA cash account, issuing company PEA-eligible. After five years of plan holding, income tax exemption on the gain (social levies still due).

How is a director's BSPCE gain taxed?#

For warrants exercised since 2025, the exercise gain is taxed at 12.8% (tenure of at least 3 years) or 30% (under 3 years), plus social levies; the later capital gain follows the 31.4% flat tax. Possible CEHR (3% / 4%) on high incomes.

How is the strike price set?#

Either aligned on a capital increase from less than 6 months ago, or set at fair market value through an appropriate method (comparables, DCF, expert valuation). Understatement triggers re-characterisation as salary benefit in kind.

Can a company older than 15 years still grant BSPCE?#

No. Article 163 bis G CGI restricts the scheme to companies under 15 years at grant. Previously granted BSPCE remain exercisable beyond the threshold.

The success of a BSPCE plan is not just about tax: it depends on the rigour of board / shareholder resolutions, the valuation memorandum, the subscription bookkeeping, the alignment with the shareholders' agreement and the link with the founder's personal holding (if any).